Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain
- PMID: 20194148
- PMCID: PMC2844010
- DOI: 10.4065/mcp.2009.0648
Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain
Abstract
Chronic neuropathic pain is a prevalent problem that eludes cure and adequate treatment. The persistence of intense and aversive symptoms, inadequacy of available treatments, and impact of such pain on all aspects of functioning underscore the important role of several psychosocial factors in causing, maintaining, and amplifying the perception of pain severity, coping adequacy, adaptation, impaired physical function, and emotional distress responses. Moreover, these factors have an influential role in response to treatment recommendations. In this article, we (1) review the prevalence and nature of emotional distress, (2) describe and propose methods for screening and comprehensive psychosocial assessment, and (3) review evidence supporting the potential complementary role of psychosocial treatments of patients with chronic pain. The cognitive-behavioral perspective and treatment approach are emphasized because the greatest amount of evidence supports their benefits. Published results of psychological treatments are modest; however, the same indictment can be placed on currently available pharmacological, medical, and interventional treatments for patients with chronic pain. We note the limited research on the effectiveness of psychological treatment specifically applied to patients with chronic neuropathic pain but suggest that it is reasonable to extrapolate from successful trials in other types of chronic pain. Furthermore, psychological approaches should not be viewed as alternatives but rather should be integrated as part of a comprehensive approach to the treatment of patients with chronic neuropathic pain.
Figures
Similar articles
-
Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations.Rev Neurol (Paris). 2020 May;176(5):325-352. doi: 10.1016/j.neurol.2020.01.361. Epub 2020 Apr 7. Rev Neurol (Paris). 2020. PMID: 32276788
-
Psychosomatic Features, Compliance and Complementary Therapies in Rheumatoid Arthritis.Curr Rheumatol Rev. 2020;16(3):215-223. doi: 10.2174/1573397115666191212114758. Curr Rheumatol Rev. 2020. PMID: 31830886 Review.
-
Cancer Pain With a Neuropathic Component: A Cross-sectional Study of Its Clinical Characteristics, Associated Psychological Distress, Treatments, and Predictors at Referral to a Cancer Pain Clinic.J Pain Symptom Manage. 2018 Feb;55(2):297-306. doi: 10.1016/j.jpainsymman.2017.08.028. Epub 2017 Sep 21. J Pain Symptom Manage. 2018. PMID: 28870800
-
Psychological aspects of neuropathic pain.Clin J Pain. 2000 Jun;16(2 Suppl):S101-5. doi: 10.1097/00002508-200006001-00017. Clin J Pain. 2000. PMID: 10870748 Review.
-
The effect of exercise therapy combined with psychological therapy on physical activity and quality of life in patients with painful diabetic neuropathy: a systematic review.Scand J Pain. 2019 Jul 26;19(3):433-439. doi: 10.1515/sjpain-2019-0001. Scand J Pain. 2019. PMID: 31112511
Cited by
-
Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress.Exp Neurol. 2012 Aug;236(2):351-62. doi: 10.1016/j.expneurol.2012.04.018. Epub 2012 May 1. Exp Neurol. 2012. PMID: 22575600 Free PMC article.
-
Increased plasma D-dimer levels may be a promising indicator for diabetic peripheral neuropathy in type 2 diabetes.Front Endocrinol (Lausanne). 2022 Aug 23;13:930271. doi: 10.3389/fendo.2022.930271. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36082076 Free PMC article.
-
The Management of Chronic Pain: Re-Centring Person-Centred Care.J Clin Med. 2023 Nov 7;12(22):6957. doi: 10.3390/jcm12226957. J Clin Med. 2023. PMID: 38002572 Free PMC article. Review.
-
Chronic postsurgical pain: current evidence for prevention and management.Korean J Pain. 2018 Jul;31(3):155-173. doi: 10.3344/kjp.2018.31.3.155. Epub 2018 Jul 2. Korean J Pain. 2018. PMID: 30013730 Free PMC article. Review.
-
Physiotherapy interventions may relieve pain in individuals with central neuropathic pain: a systematic review and meta-analysis of randomised controlled trials.Ther Adv Chronic Dis. 2022 Mar 24;13:20406223221078672. doi: 10.1177/20406223221078672. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35356293 Free PMC article.
References
-
- Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain. 2002;18(5):355-365 - PubMed
-
- Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage. 2008;35(2):214-228 - PubMed
-
- Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97(4):1097-1102 - PubMed
-
- Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004;28(3):250-258 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources